Home News & Updates

News & Updates

FDA Grants Accelerated Approval for Alzheimer’s Drug

  Update   June 7, 2021   Uncategorized

Study: Impact of International Reference Pricing on Alzheimer’s Research and Development

  Update   April 22, 2021   Uncategorized

Sponsor Spotlight: Avanir’s Sanjay Dubé, M.D.

  Update   March 3, 2021   Sponsor Spotlight

13th Annual FDA/ACT-AD Allies Meeting Recap

  Update   February 17, 2021   Uncategorized

ACT-AD Member Spotlight: BrightFocus Foundation

  Update   November 25, 2019   Updates

ACT-AD at the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

  Update   October 31, 2018   Event Recap

ACT-AD Letter on FDA Early Alzheimer’s Disease Guidance

  Update   June 15, 2018   FDA

Researchers Reverse Alzheimer’s Disease in Mouse Models

  Update   February 10, 2018   Uncategorized

Experimental Drug Could Be Viable Treatment for Alzheimer’s Disease

  Update   January 19, 2018   Uncategorized

Canola Oil May Play a Role in Worsening of Alzheimer’s Disease Symptoms

  Update   December 28, 2017   Uncategorized